Xvivo System model X2
— The 21st Century GMP Quality Platform for processing and producing clinical grade cells.
All
Testimonials
Uncategorized
June 28, 2021
BioSpherix Collaborates with Industry Leaders at the New RegeneratOR Test Bed to Advance Regenerative Medicine
June 18, 2020
BioSpherix partners with Sexton Biotechnologies on modular fill-finish for cell and gene therapies
June 1, 2020
Next Generation Isolators at Canadian Hospitals to begin COVID-19 clinical trials
May 25, 2020
BioSpherix ramps up production again after COVID pause!
April 16, 2020
Selecting The Right Isolator For Cell Therapy Manufacturing: Considerations & Challenges
February 25, 2020
More Cell and Gene Therapy Facilities in the Hundreds are Needed
May 7, 2019
Point-of-Use Inoculum Prep
April 22, 2019
ISPE 2019: Closing Down the Process – The Future of Cell and Gene Therapy Manufacturing
November 21, 2018
Advanced Regenerative Manufacturing Institute (ARMI) New Member Spotlight
October 23, 2018
BioSpherix Medical Chosen by ACF Bioservices™
October 19, 2018
Cleanrooms West and BioSpherix Medical Collaboration
October 17, 2018
Hodess Cleanrooms Installs GMP Isolator Into Wall
October 11, 2018
Testimonial: Bristol-Myers Squibb
October 4, 2018
BioSpherix Announces Facility and Capacity Expansion
August 3, 2018
BioSpherix seen on National Geographic: Miracle Hospital
July 18, 2018
Could reducing cell manufacturing fluctuations help customers like Novartis improve their cell variability issues for Kymriah?
July 12, 2018
Institute for Vision Research Announces a Culture System for Human Donor Retina
June 20, 2018
BioSpherix Sponsors the 2018 ISSCR Meeting in Melbourne!
May 16, 2018
BioSpherix Medical at ASGCT
May 8, 2018
BioSpherix Medical at ISCT in Montreal
April 30, 2018
BioSpherix Medical Announces Successful Completion of F.A.T. Test
April 17, 2018
BioSpherix Medical will be attending Interphex in NYC
March 12, 2018
Death to Cleanrooms!
February 27, 2018
A Short guide to Cell Therapy Manufacturing, Pt. 2
February 1, 2018
BioSpherix Medical Announces New Partnership
BioSpherix will be adapting all operations to the pandemic and recent New York State Covid-19 Business Mandates. We apologize for any inconveniences this may cause.
